# FDA Inspection 1224373 - Rubicon Research Canada Limited - November 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/rubicon-research-canada-limited/5b5f8227-d3d2-4f55-a978-68d5ddb6ee21
Source feed: FDA_Inspections

> FDA Inspection 1224373 for Rubicon Research Canada Limited on November 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224373
- Company Name: Rubicon Research Canada Limited
- Inspection Date: 2023-11-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1073583 - 2018-10-18](https://www.keypedia.com/records/fda_inspections/rubicon-research-canada-limited/3a8c60cf-2fb8-420c-847b-e336bb5981ea)
- [FDA Inspection 981956 - 2016-07-27](https://www.keypedia.com/records/fda_inspections/rubicon-research-canada-limited/ea64b0b1-cb1c-48eb-8fa2-ab96def71818)

Company: https://www.keypedia.com/companies/rubicon-research-canada-limited/807792a8-f94f-4118-8583-a18125ce41f8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c